• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在杜氏肌营养不良症的斑马鱼模型中进行药物筛选。

Drug screening in a zebrafish model of Duchenne muscular dystrophy.

机构信息

Division of Genetics, Program in Genomics, Children's Hospital, Boston, MA 02115, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5331-6. doi: 10.1073/pnas.1102116108. Epub 2011 Mar 14.

DOI:10.1073/pnas.1102116108
PMID:21402949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3069215/
Abstract

Two known zebrafish dystrophin mutants, sapje and sapje-like (sap(c/100)), represent excellent small-animal models of human muscular dystrophy. Using these dystrophin-null zebrafish, we have screened the Prestwick chemical library for small molecules that modulate the muscle phenotype in these fish. With a quick and easy birefringence assay, we have identified seven small molecules that influence muscle pathology in dystrophin-null zebrafish without restoration of dystrophin expression. Three of seven candidate chemicals restored normal birefringence and increased survival of dystrophin-null fish. One chemical, aminophylline, which is known to be a nonselective phosphodiesterase (PDE) inhibitor, had the greatest ability to restore normal muscle structure and up-regulate the cAMP-dependent PKA pathway in treated dystrophin-deficient fish. Moreover, other PDE inhibitors also reduced the percentage of affected sapje fish. The identification of compounds, especially PDE inhibitors, that moderate the muscle phenotype in these dystrophin-null zebrafish validates the screening protocol described here and may lead to candidate molecules to be used as therapeutic interventions in human muscular dystrophy.

摘要

两种已知的斑马鱼肌营养不良蛋白突变体,sapje 和 sapje-like(sap(c/100)),代表了人类肌肉营养不良症的优秀小型动物模型。我们使用这些肌营养不良蛋白缺失的斑马鱼,在 Prestwick 化学文库中筛选了能够调节这些鱼类肌肉表型的小分子。通过快速简便的双折射测定法,我们已经鉴定出七种小分子,它们可以影响肌营养不良蛋白缺失的斑马鱼的肌肉病理学,而不恢复肌营养不良蛋白的表达。在七种候选化学物质中,有三种能够恢复正常的双折射并提高肌营养不良蛋白缺失鱼类的存活率。一种化学物质氨茶碱,已知是一种非选择性磷酸二酯酶(PDE)抑制剂,它具有最大的能力来恢复正常的肌肉结构,并上调治疗后肌营养不良蛋白缺陷鱼类中的 cAMP 依赖性 PKA 途径。此外,其他 PDE 抑制剂也降低了受影响的 sapje 鱼的百分比。在这些肌营养不良蛋白缺失的斑马鱼中,能够调节肌肉表型的化合物的鉴定,特别是 PDE 抑制剂,验证了这里描述的筛选方案,并可能导致候选分子被用作人类肌肉营养不良症的治疗干预措施。

相似文献

1
Drug screening in a zebrafish model of Duchenne muscular dystrophy.在杜氏肌营养不良症的斑马鱼模型中进行药物筛选。
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5331-6. doi: 10.1073/pnas.1102116108. Epub 2011 Mar 14.
2
Zebrafish based small molecule screens for novel DMD drugs.基于斑马鱼的新型杜氏肌营养不良症药物小分子筛选
Drug Discov Today Technol. 2013 Spring;10(1):e91-6. doi: 10.1016/j.ddtec.2012.03.001.
3
Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment.肌功能障碍和肌营养不良蛋白缺失的 sapje 突变体斑马鱼幼虫的结构缺陷可通过阿托伦治疗得到挽救。
FASEB J. 2014 Apr;28(4):1593-9. doi: 10.1096/fj.13-240044. Epub 2013 Dec 26.
4
Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.斑马鱼肌营养不良蛋白剪接突变体的基因分离与特征分析
Hum Mol Genet. 2009 Jan 1;18(1):202-11. doi: 10.1093/hmg/ddn337. Epub 2008 Oct 28.
5
Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.通过增强血红素加氧酶信号通路改善斑马鱼的营养不良性肌肉
Hum Mol Genet. 2014 Apr 1;23(7):1869-78. doi: 10.1093/hmg/ddt579. Epub 2013 Nov 13.
6
Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.磷酸肌醇转移蛋白 α 的抑制可改善杜氏肌营养不良症的病理。
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6080-6085. doi: 10.1073/pnas.1703556114. Epub 2017 May 22.
7
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.氟西汀可预防杜氏肌营养不良症斑马鱼模型中的营养不良性变化。
Hum Mol Genet. 2014 Sep 1;23(17):4651-62. doi: 10.1093/hmg/ddu185. Epub 2014 Apr 23.
8
PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.PDE10A 抑制可减轻 DMD 斑马鱼的病理表现,并抑制遗传修饰因子 PITPNA。
Mol Ther. 2021 Mar 3;29(3):1086-1101. doi: 10.1016/j.ymthe.2020.11.021. Epub 2020 Nov 20.
9
Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology.肌营养不良症相关病理特征出现在肌营养不良蛋白缺陷型斑马鱼中。
Neuromuscul Disord. 2010 Dec;20(12):826-32. doi: 10.1016/j.nmd.2010.08.004. Epub 2010 Sep 17.
10
Zebrafish based small molecule screens for novel DMD drugs.基于斑马鱼的新型杜氏肌营养不良症药物小分子筛选
Drug Discov Today Technol. 2013 Spring;10(1):e91-e96. doi: 10.1016/j.ddtec.2012.03.001.

引用本文的文献

1
Zebrafish Models of Induced Lymphangiogenesis: Current Advancements and Therapeutic Discovery.诱导性淋巴管生成的斑马鱼模型:当前进展与治疗发现
Pharmaceuticals (Basel). 2025 Jul 21;18(7):1076. doi: 10.3390/ph18071076.
2
Identifying kinematic biomarkers of the dystrophic phenotype in a zebrafish model of Duchenne muscular dystrophy.在杜兴氏肌营养不良症的斑马鱼模型中鉴定营养不良表型的运动生物标志物。
Skelet Muscle. 2025 Jun 20;15(1):17. doi: 10.1186/s13395-025-00382-6.
3
Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviour.对抗精神病药物对鱼类潜在风险的关键见解,包括对行为的影响。
Biol Rev Camb Philos Soc. 2025 Oct;100(5):1994-2019. doi: 10.1111/brv.70031. Epub 2025 May 12.
4
ZFIN updates to support zebrafish environmental exposure data.ZFIN更新以支持斑马鱼环境暴露数据。
Genetics. 2025 Mar 17;229(3). doi: 10.1093/genetics/iyaf021.
5
Modeling Musculoskeletal Disorders in Zebrafish: Advancements in Muscle and Bone Research.斑马鱼骨骼肌肉疾病建模:肌肉与骨骼研究进展
Cells. 2024 Dec 30;14(1):28. doi: 10.3390/cells14010028.
6
High resolution kinematic approach for quantifying impaired mobility of dystrophic zebrafish larvae.用于量化营养不良斑马鱼幼体运动功能受损的高分辨率运动学方法。
bioRxiv. 2024 Dec 9:2024.12.05.627004. doi: 10.1101/2024.12.05.627004.
7
Uncovering the Embryonic Origins of Duchenne Muscular Dystrophy.揭示杜氏肌营养不良症的胚胎起源。
WIREs Mech Dis. 2024 Nov-Dec;16(6):e1653. doi: 10.1002/wsbm.1653. Epub 2024 Oct 23.
8
Aligning with the 3Rs: alternative models for research into muscle development and inherited myopathies.与 3Rs 保持一致:肌肉发育和遗传性肌肉疾病研究的替代模型。
BMC Vet Res. 2024 Oct 18;20(1):477. doi: 10.1186/s12917-024-04309-z.
9
A Zebrafish-Based Platform for High-Throughput Epilepsy Modeling and Drug Screening in F0.基于斑马鱼的F0代高通量癫痫建模与药物筛选平台。
Int J Mol Sci. 2024 Mar 4;25(5):2991. doi: 10.3390/ijms25052991.
10
Standardization of zebrafish drug testing parameters for muscle diseases.斑马鱼肌肉疾病药物测试参数的标准化。
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050339. Epub 2024 Jan 18.

本文引用的文献

1
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.西地那非逆转 Duchenne 肌营养不良症 mdx 小鼠模型的心脏功能障碍。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19079-83. doi: 10.1073/pnas.1013077107. Epub 2010 Oct 18.
2
Zebrafish models for human FKRP muscular dystrophies.人类 FKRP 肌营养不良症的斑马鱼模型。
Hum Mol Genet. 2010 Feb 15;19(4):623-33. doi: 10.1093/hmg/ddp528. Epub 2009 Dec 1.
3
Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.斑马鱼肌营养不良蛋白剪接突变体的基因分离与特征分析
Hum Mol Genet. 2009 Jan 1;18(1):202-11. doi: 10.1093/hmg/ddn337. Epub 2008 Oct 28.
4
Sarcolemma-localized nNOS is required to maintain activity after mild exercise.轻度运动后,维持活性需要肌膜定位的神经元型一氧化氮合酶。
Nature. 2008 Nov 27;456(7221):511-5. doi: 10.1038/nature07414. Epub 2008 Oct 26.
5
Genes required for functional glycosylation of dystroglycan are conserved in zebrafish.与肌营养不良蛋白聚糖功能糖基化所需的基因在斑马鱼中是保守的。
Genomics. 2008 Sep;92(3):159-67. doi: 10.1016/j.ygeno.2008.05.008. Epub 2008 Jul 15.
6
Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).与福金相关蛋白(FKRP)缺失相关的肌营养不良斑马鱼模型中的发育缺陷
Brain. 2008 Jun;131(Pt 6):1551-61. doi: 10.1093/brain/awn078. Epub 2008 May 13.
7
Local dystrophin restoration with antisense oligonucleotide PRO051.使用反义寡核苷酸PRO051进行局部肌营养不良蛋白恢复
N Engl J Med. 2007 Dec 27;357(26):2677-86. doi: 10.1056/NEJMoa073108.
8
Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.功能性缺血的主要作用、双打击机制的定量证据,以及磷酸二酯酶-5 抑制剂在小鼠肌肉疾病中的治疗作用。
PLoS One. 2007 Aug 29;2(8):e806. doi: 10.1371/journal.pone.0000806.
9
PTC124 targets genetic disorders caused by nonsense mutations.PTC124靶向由无义突变引起的遗传性疾病。
Nature. 2007 May 3;447(7140):87-91. doi: 10.1038/nature05756. Epub 2007 Apr 22.
10
Zebrafish orthologs of human muscular dystrophy genes.人类肌肉萎缩症基因的斑马鱼直系同源基因。
BMC Genomics. 2007 Mar 20;8:79. doi: 10.1186/1471-2164-8-79.